Enjoy complimentary customisation on priority with our Enterprise License!
The blood glucose monitoring market share in APAC is expected to increase by USD 1.62 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.05%.
This blood glucose monitoring market in APAC research report extensively covers blood glucose monitoring market segmentation in APAC by:
The blood glucose monitoring market vendors in APAC are - Abbott Laboratories, ACON Laboratories Inc., Advin Health Care, ARKRAY Inc., Bionime Corp., Dexcom Inc., F. Hoffmann La Roche Ltd., Hangzhou Sejoy Electronics and Instruments Co. Ltd., Johnson and Johnson services Inc., medisana GmbH, Medtronic Plc, Novo Nordisk AS, PHC Holdings Corp., Pulsatom Healthcare Pvt. Ltd., Rossmax International Ltd., SiBionics, Sinocare Inc., WaveForm Technologies Inc., and Zhejiang POCTech Co. Ltd. among others.
Download the Free Report Sample to Unlock the Blood Glucose Monitoring Market Size in APAC for the Forecast Period and Other Important Statistics
The rise in diabetic population is notably driving the blood glucose monitoring market growth in APAC, although factors such as lower diagnosis and treatment rate may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the blood glucose monitoring industry in APAC. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Blood Glucose Monitoring Market Driver in APAC
Key Blood Glucose Monitoring Market Trend in APAC
Key Blood Glucose Monitoring Market Challenge in APAC
This blood glucose monitoring market in APAC analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the blood glucose monitoring market in APAC as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the blood glucose monitoring market in APAC during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the blood glucose monitoring market in APAC encompasses successful business strategies deployed by the key vendors. The blood glucose monitoring market in APAC is fragmented and the vendors are deploying growth strategies such as focusing on differentiating themselves by offering value-added services and competitive pricing to compete in the market.
abbott.com - The company offers blood glucose monitoring devices under the brand name Freestyle, that offer a range of features to meet the specific needs of people living with diabetes.
abbott.com - Under the established pharmaceuticals products segment, the company manufacturers branded generic pharmaceuticals for established and emerging markets.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The blood glucose monitoring market in APAC forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the blood glucose monitoring market in APAC, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The blood glucose monitoring market share growth in APAC by the SMBG segment will be significant during the forecast period. The SMBG segment is organized and will grow rapidly because of the rise in the prevalence of diabetes in APAC. India and China rank high in terms of diabetic populations in the world, and the prevalence of diabetes is expected to increase at a high rate in both countries during the forecast period. With the availability of innovative and advanced SMBG devices, the market is expected to witness a significant rise in the sales of these devices.
This report provides an accurate prediction of the contribution of all the segments to the growth of the blood glucose monitoring market size in APAC and actionable market insights on post COVID-19 impact on each segment.
Blood Glucose Monitoring System market - The market share is expected to increase to USD 5.62 billion by 2026 at a progressing CAGR of 9.06%.
Blood Glucose Monitoring Devices market - The market share is expected to increase by USD 5.84 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 8.16%.
Blood Glucose Monitoring Market Scope in APAC |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.05% |
Market growth 2022-2026 |
$ 1.62 billion |
Market structure |
Fragmented |
YoY growth (%) |
8.45 |
Regional analysis |
APAC |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, ACON Laboratories Inc., Advin Health Care, ARKRAY Inc., Bionime Corp., Dexcom Inc., F. Hoffmann La Roche Ltd., Hangzhou Sejoy Electronics and Instruments Co. Ltd., Johnson and Johnson services Inc., medisana GmbH, Medtronic Plc, Novo Nordisk AS, PHC Holdings Corp., Pulsatom Healthcare Pvt. Ltd., Rossmax International Ltd., SiBionics, Sinocare Inc., WaveForm Technologies Inc., and Zhejiang POCTech Co. Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.